Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

27.62
Delayed Data
As of Jul 20
 +0.27 / +0.99%
Today’s Change
9.69
Today|||52-Week Range
37.69
+55.78%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close27.35
Today’s open27.69
Day’s range26.42 - 27.93
Volume38,814
Average volume (3 months)29,873
Market cap$232.3M
Dividend yield--
Data as of 3:59pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+40.08%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.08-0.85%
SBBPStrongbridge Biophar...+0.20+3.03%
IMDZImmune Design Corp+0.20+2.19%
PPHMPeregrine Pharmaceut...+0.02+0.38%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ron Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts